Zobrazeno 1 - 10
of 36
pro vyhledávání: '"Szilárd Pál"'
Autor:
Dávid Sipos, Adorján Varga, Ágnes Kappéter, Bernadett Halda-Kiss, Péter Kása, Szilárd Pál, Béla Kocsis, Zoltán Péterfi
Publikováno v:
Frontiers in Cellular and Infection Microbiology, Vol 14 (2024)
IntroductionClostridioides difficile infections (CDI) continue to pose a challenge for clinicians. Fecal microbiota transplantation (FMT) is an effective treatment option in CDI. Furthermore, recent and ongoing studies suggest potential benefits of F
Externí odkaz:
https://doaj.org/article/6e5e52bc201a4fa6872c08cc725849af
Publikováno v:
Nanomaterials, Vol 14, Iss 19, p 1561 (2024)
This study presents a reproducible and scalable method for synthesizing silica nanoparticles (SNPs) with controlled sizes below 200 nm, achieved by systematically varying three key reaction parameters: ammonium hydroxide concentration, water concentr
Externí odkaz:
https://doaj.org/article/e16eff90689a4d4990766cbaa2593d2a
Publikováno v:
Pharmaceutics, Vol 16, Iss 3, p 405 (2024)
The flow properties of pellets or granules are crucial for further processing drug dosage forms. Optimal compression or filling of multiparticulate dosage forms into capsules is influenced by forces between discrete particles, which could be partiall
Externí odkaz:
https://doaj.org/article/09afecf5a494451199a437b1fbca47af
Autor:
Barbara Vörös-Horváth, Pavo Živković, Krisztina Bánfai, Judit Bóvári-Biri, Judit Pongrácz, Gábor Bálint, Szilárd Pál, Aleksandar Széchenyi
Publikováno v:
ACS Omega, Vol 7, Iss 4, Pp 3240-3253 (2022)
Externí odkaz:
https://doaj.org/article/00ec0f2bb64040bbb786936b195d81be
Autor:
Adorján Varga, Lilla Makszin, Anita Bufa, Dávid Sipos, Péter Kása, Szilárd Pál, Philip Rosenstiel, Felix Sommer, Béla Kocsis, Zoltán Péterfi
Publikováno v:
Frontiers in Cellular and Infection Microbiology, Vol 13 (2023)
Background and aimsFaecal microbiota transfer (FMT) has managed to earn its place in the Clostridioides difficile infection (CDI) guidelines by having comparable efficacy and recurrence rate of fidaxomicin. After more than 100 successful FMT administ
Externí odkaz:
https://doaj.org/article/8e1f6287568549c58081701c17f70685
Autor:
Adorján Varga, Béla Kocsis, Dávid Sipos, Péter Kása, Szabolcs Vigvári, Szilárd Pál, Fanni Dembrovszky, Kornélia Farkas, Zoltán Péterfi
Publikováno v:
Frontiers in Cellular and Infection Microbiology, Vol 11 (2021)
PurposeMetronidazol and vancomycin were long the two best options against Clostridioides (formerly Clostridium) difficile infections (CDI). Now, the cost of new drugs such as fidaxomicin directs us towards alternative treatment options, such as faeca
Externí odkaz:
https://doaj.org/article/245b23804bcc40c18917cb5d7f54ccad
Autor:
Csongor Bakó, Viktória Lilla Balázs, Gyöngyi Takács, József Péter Pallos, Szilárd Pál, Béla Kocsis, Dóra Rippelné Pethő, Györgyi Horváth
Publikováno v:
Molecules, Vol 26, Iss 21, p 6449 (2021)
The extraction of clary sage (Salvia sclarea L.) using supercritical carbon dioxide (SC-CO2) was systematically studied by using thin layer chromatography-direct bioautography (TLC-DB) and response surface methodology (RSM). The three parameters temp
Externí odkaz:
https://doaj.org/article/8e67885666a243d986669df466f716ef
Autor:
Ádám István Horváth, Nikolett Szentes, Valéria Tékus, Maja Payrits, Éva Szőke, Emőke Oláh, András Garami, Eszter Fliszár-Nyúl, Miklós Poór, Cecília Sár, Tamás Kálai, Szilárd Pál, Krisztina Percze, Éva Nagyné Scholz, Tamás Mészáros, Blanka Tóth, Péter Mátyus, Zsuzsanna Helyes
Publikováno v:
Biomedicines, Vol 9, Iss 7, p 749 (2021)
SZV 1287 (3-(4,5-diphenyl-1,3-oxazol-2-yl)propanal oxime) is a novel multi-target candidate under preclinical development for neuropathic pain. It inhibits amine oxidase copper containing 3, transient receptor potential ankyrin 1 and vanilloid 1 (TRP
Externí odkaz:
https://doaj.org/article/b78a30cd91f84207aab5435c4944b4c9
Autor:
Ala’ Salem, Anna Takácsi-Nagy, Sándor Nagy, Alexandra Hagymási, Fruzsina Gősi, Barbara Vörös-Horváth, Tomislav Balić, Szilárd Pál, Aleksandar Széchenyi
Publikováno v:
Pharmaceutics, Vol 13, Iss 2, p 277 (2021)
Drug–drug cocrystals are formulated to produce combined medication, not just to modulate active pharmaceutical ingredient (API) properties. Nano-crystals adjust the pharmacokinetic properties and enhance the dissolution of APIs. Nano-cocrystals see
Externí odkaz:
https://doaj.org/article/9a6a12700e9346a8a98e7fbd935a7150
Autor:
Barbara Vörös-Horváth, Sourav Das, Ala’ Salem, Sándor Nagy, Andrea Böszörményi, Tamás Kőszegi, Szilárd Pál, Aleksandar Széchenyi
Publikováno v:
Molecules, Vol 25, Iss 23, p 5544 (2020)
Onychomycosis is a disease that affects many adults, whose treatment includes both oral and topical therapies with low cure rates. The topical therapy is less effective but causes fewer side effects. This is why the development of an effective, easy
Externí odkaz:
https://doaj.org/article/f2a335b10c8b459398195305669dcf1b